These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

347 related items for PubMed ID: 15896748

  • 1. Effect of long-term calcitonin administration on steroid-induced osteoporosis after cardiac transplantation.
    Kapetanakis EI, Antonopoulos AS, Antoniou TA, Theodoraki KA, Zarkalis DA, Sfirakis PD, Chilidou DA, Alivizatos PA.
    J Heart Lung Transplant; 2005 May; 24(5):526-32. PubMed ID: 15896748
    [Abstract] [Full Text] [Related]

  • 2. Better late than never? Experience with intravenous pamidronate treatment in patients with low bone mass or fractures following cardiac or liver transplantation.
    Dodidou P, Bruckner T, Hosch S, Haass M, Klar E, Sauer P, Ziegler R, Leidig-Bruckner G.
    Osteoporos Int; 2003 Jan; 14(1):82-9. PubMed ID: 12577189
    [Abstract] [Full Text] [Related]

  • 3. The effect of low-dose cholecalciferol and calcium treatment on posttransplant bone loss in renal transplant patients: a prospective study.
    Sahin G, Yasar NS, Sirmagul B, Bal C, Yalcin AU.
    Ren Fail; 2008 Jan; 30(10):992-9. PubMed ID: 19016151
    [Abstract] [Full Text] [Related]

  • 4. Comparison of calcitonin versus calcitonin + resistance exercise as prophylaxis for osteoporosis in heart transplant recipients.
    Braith RW, Magyari PM, Fulton MN, Lisor CF, Vogel SE, Hill JA, Aranda JM.
    Transplantation; 2006 Apr 27; 81(8):1191-5. PubMed ID: 16641607
    [Abstract] [Full Text] [Related]

  • 5. A prospective study of bone loss and turnover after cardiac transplantation: effect of calcium supplementation with or without calcitonin.
    Välimäki MJ, Kinnunen K, Tähtelä R, Löyttyniemi E, Laitinen K, Mäkelä P, Keto P, Nieminen M.
    Osteoporos Int; 1999 Apr 27; 10(2):128-36. PubMed ID: 10501793
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [The clinical benefits to bone mineral density were shown by cyclical oral etidronate administration in steroid induced osteoporosis].
    Nakamura T, Maekawa S, Morinobu S, Morinobu A, Koshiba M, Yamauchi M, Sugimoto T, Kumagai S.
    Ryumachi; 2002 Aug 27; 42(4):666-75. PubMed ID: 12355861
    [Abstract] [Full Text] [Related]

  • 8. [Effect of immunosuppression-induced hypogonadism on bone metabolism after heart transplantation].
    Stief J, Sohn HY, Alt A, Uberfuhr P, Theisen K, Stempfle HU.
    Dtsch Med Wochenschr; 2004 Jul 30; 129(31-32):1674-8. PubMed ID: 15273918
    [Abstract] [Full Text] [Related]

  • 9. Lumbar bone mineral density in renal transplant patients on neoral and tacrolimus: a four-year prospective study.
    Marcén R, Caballero C, Pascual J, Teruel JL, Tenorio M, Ocaña J, Villafruela JJ, Burgos FJ, Fernández AM, Muriel A, Ortuño J.
    Transplantation; 2006 Mar 27; 81(6):826-31. PubMed ID: 16570003
    [Abstract] [Full Text] [Related]

  • 10. Clodronate treatment of established bone loss in cardiac recipients: a randomized study.
    Ippoliti G, Pellegrini C, Campana C, Rinaldi M, D'Armini A, Goggi C, Aiello M, Viganò M.
    Transplantation; 2003 Feb 15; 75(3):330-4. PubMed ID: 12589153
    [Abstract] [Full Text] [Related]

  • 11. Steroid-induced fractures and bone loss in patients with asthma.
    Adinoff AD, Hollister JR.
    N Engl J Med; 1983 Aug 04; 309(5):265-8. PubMed ID: 6866051
    [Abstract] [Full Text] [Related]

  • 12. Longterm effect of intermittent cyclical etidronate therapy on corticosteroid-induced osteoporosis in Japanese patients with connective tissue disease: 7-year followup.
    Sato S, Takada T, Katsuki Y, Kimura N, Kaneko Y, Suwa A, Hirakata M, Kuwana M.
    J Rheumatol; 2008 Jan 04; 35(1):142-6. PubMed ID: 18050368
    [Abstract] [Full Text] [Related]

  • 13. Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 9. Calcitonin in the treatment of osteoporosis.
    Siminoski K, Josse RG.
    CMAJ; 1996 Oct 01; 155(7):962-5. PubMed ID: 8837547
    [Abstract] [Full Text] [Related]

  • 14. A randomized controlled trial of salmon calcitonin to prevent bone loss in corticosteroid-treated temporal arteritis and polymyalgia rheumatica.
    Healey JH, Paget SA, Williams-Russo P, Szatrowski TP, Schneider R, Spiera H, Mitnick H, Ales K, Schwartzberg P.
    Calcif Tissue Int; 1996 Feb 01; 58(2):73-80. PubMed ID: 8998681
    [Abstract] [Full Text] [Related]

  • 15. Prevention of early loss of bone mineral density after liver transplantation by prostaglandin E1.
    Hommann M, Kämmerer D, Lehmann G, Kornberg A, Küpper B, Daffner W, Wolf G, Settmacher U.
    Transplant Proc; 2007 Mar 01; 39(2):540-3. PubMed ID: 17362777
    [Abstract] [Full Text] [Related]

  • 16. Prevention of corticosteroid induced osteoporosis in inpatients recently discharged from a tertiary teaching hospital.
    Smith MD, Cheah SP, Taylor K, Ahern MJ.
    J Rheumatol; 2001 Mar 01; 28(3):566-70. PubMed ID: 11296960
    [Abstract] [Full Text] [Related]

  • 17. Pamidronate in the prevention of bone loss after liver transplantation: a randomized controlled trial.
    Monegal A, Guañabens N, Suárez MJ, Suárez F, Clemente G, García-González M, De la Mata M, Serrano T, Casafont F, Tome S, Barrios C, Navasa M.
    Transpl Int; 2009 Feb 01; 22(2):198-206. PubMed ID: 18796000
    [Abstract] [Full Text] [Related]

  • 18. The effects of daily alendronate, daily calcitonin and alendronate every other day on bone mineral density in osteoporotic men.
    Guven Z, Karadag-Saygi E, Unlu-Ozkan F, Akyuz G.
    Aging Male; 2007 Dec 01; 10(4):197-201. PubMed ID: 18033629
    [Abstract] [Full Text] [Related]

  • 19. Prevention of loss of vertebral bone density in heart transplant patients.
    Muchmore JS, Cooper DK, Ye Y, Schlegel V, Pribil A, Zuhdi N.
    J Heart Lung Transplant; 1992 Dec 01; 11(5):959-63; discussion 963-4. PubMed ID: 1420245
    [Abstract] [Full Text] [Related]

  • 20. The effects of calcitonin on bone resorption in hyperthyroidism: a placebo-controlled clinical study.
    Akçay MN, Akçay G, BIlen H.
    J Bone Miner Metab; 2004 Dec 01; 22(2):90-3. PubMed ID: 14999518
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.